Locate Bio raises £2.25m for new spinal treatments

Locate Bio, who are developing new treatments for patients with serious spinal conditions, has completed a £2.25m funding round led by Mercia Asset Management to help to continue its ground-breaking research and bring its first products to market. Locate Bio has secured the investment from Mercia’s own balance sheet, its EIS...

PROTAC Assays – Successfully measuring Protein Degradation

PROTAC (PROteolysis TArgeting Chimera) is one of the hottest topics in drug discovery today as it is a highly promising new approach to targeted therapy. It offers several advantages over traditional occupancy-based drugs, with a potential to target the ‘undruggable’ proteome. Read Aurelia Bioscience's blog below to learn more about PROTAC...

A Practical Guide to Developing Software For Medical Devices

In eg Technology's final webinar of their Product Design and Development of Medical Device series, in association with SEHTA, eg technology Director, David Warwick, used his extensive knowledge and experience of computer systems engineering and medical device design to talk us through some practical advice on the development of software...

Bright Future for Life Sciences in the Midlands

The amalgamation of Medilink East and West Midlands has been given the seal of approval in a move which will serve the best interests of the life sciences sector in the Midlands. This unification, that sees Medilink East and West Midlands operate under a single group company, Medilink Midlands, was...

5 top tips for your first R&D Tax Credit Claim

There are many reasons why a company is yet to claim R&D Tax Relief. You might be a new business, a start-up or a university spin-out; you might have recently come across the scheme for the first time; you may have previously thought you were ineligible, or you may have...

UK-EU Trade Deal, What’s the State of Play?

A Business Leader’s View of the Negotiations Over the past few months, the UK’s focus has understandably been on managing the Coronavirus pandemic and subsequent lockdowns. But the question of Brexit has not gone away. Chief Executive of Morningside Pharmaceuticals, Dr Nik Kotecha OBE, gives his view on the negotiations.   ...

The benefits of R&D Tax Relief for Start-ups

During the first few years of a running a start-up business, claiming R&D Tax Relief may be far from the top of your priorities. However, making a claim could return a significant amount of much-needed cash to your business. Many technology-based start-up businesses are innovative by their very nature. They’re usually created...